A Tool to Utilize Adverse Effect Profiles to Identify Brain-Active Medications for Repurposing

BACKGROUND: To shorten the time required to bring new treatments to clinics, recent efforts have focused on repurposing existing Food and Drug Administration (FDA)-approved drugs with established safety data for new indications. We hypothesized that adverse effect profiles might aid in prioritizing...

Descripción completa

Detalles Bibliográficos
Autores principales: McCoy, Thomas H., Perlis, Roy H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360243/
https://www.ncbi.nlm.nih.gov/pubmed/25673184
http://dx.doi.org/10.1093/ijnp/pyu078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360243/
https://www.ncbi.nlm.nih.gov/pubmed/25673184
http://dx.doi.org/10.1093/ijnp/pyu078

Ejemplares similares